According to Pluo Pharmaceutical's announcement, the company's share repurchase is used to cancel and reduce registered capital. The maximum repurchase price is not more than 20 yuan/share, and the total repurchase capital is not less than 100 million yuan and not more than 150 million yuan. The repurchase period is within 6 months from the date the shareholders' meeting reviews and approves the plan. As of August 31, 2026, the company had repurchased a total of 5.4101 million shares through centralized bidding transactions, accounting for 0.47% of the total share capital. The highest transaction price was 19.98 yuan/share, the lowest transaction price was 17.05 yuan/share, and the total transaction amount was 99.9897 million yuan.

Zhitongcaijing · 3d ago
According to Pluo Pharmaceutical's announcement, the company's share repurchase is used to cancel and reduce registered capital. The maximum repurchase price is not more than 20 yuan/share, and the total repurchase capital is not less than 100 million yuan and not more than 150 million yuan. The repurchase period is within 6 months from the date the shareholders' meeting reviews and approves the plan. As of August 31, 2026, the company had repurchased a total of 5.4101 million shares through centralized bidding transactions, accounting for 0.47% of the total share capital. The highest transaction price was 19.98 yuan/share, the lowest transaction price was 17.05 yuan/share, and the total transaction amount was 99.9897 million yuan.